Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

6 Jan 2011 07:00

RNS Number : 9885Y
Concurrent Technologies PLC
06 January 2011
 



Concurrent Technologies Plc

 

Product Launch

 

Two New Products using latest 2nd generation Intel® Core™ processors

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products, is pleased to announce the launch of two new high performance VME/VXS and VPX processor boards. Significantly, both new products utilize the very latest quad-core or dual-core 2nd generation Intel®Core™ processors announced by Intel®in the first week of January 2011. These processors offer enhanced processing and graphic capabilities, resulting in virtually double the graphics performance of previous generations.

 

Following the Company's strategy to develop and release products using the most advanced technology as soon as it is available, both processor boards provide ideal upgrade paths to current products, offering existing and new customers the opportunity to upgrade their systems to the latest processing technology.

 

Both of today's products have been developed to provide superior performance and features over previous generations of boards and are particularly aimed at the defence and security market segments. They are the first of a planned family of boards using this latest technology, with a further two products planned for launch within the first half of 2011. Extended temperature and ruggedized variants of these boards will be available in the coming months.

 

Glen Fawcett, Managing Director, Concurrent Technologies Plc, commented:

 

"I am delighted that we have again been able to demonstrate that our dedicated close partnership with Intel® enables us to release these two new advanced products immediately following the technology release from Intel®. Our customers demand the very latest processing technology for their applications, and this platform delivers significant improvements over the previous generation."

"This release shows our continuing commitment to introducing leading edge embedded processing technology to the market as early as possible, which is essential for us to remain as a world-leading high end developer."

 

6th January 2011

 

Enquiries:

 

Concurrent Technologies Plc Glen Fawcett, Managing Director +44 (0)1206 752 626

 

NexFin (Financial PR) Nicholas Nelson +44 (0)7921 522920

 

Cenkos Securities Plc (NOMAD)

Ken Fleming +44 (0)131 220 6939

Beth McKiernan +44 (0)131 220 9778

 

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

Note to Editors:

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel® processors, including the latest 2nd generation Intel® Core™, Intel® Core™ i7 processors, Intel® Xeon®, Atom™ and Core™ 2 dual-core processors, the Company offers a wide range of computer products which are designed to be compliant with the most stringent industry specifications including those for products used in extremely harsh environments.

 

For more information on Concurrent and its products please visit http://www.cct.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLBAMRTMBIMBPB
Date   Source Headline
22nd May 20183:41 pmRNSAGM Statement
21st May 20187:00 amRNSProduct Announcement
30th Apr 20189:30 amRNSDistribution of Annual Report and Accounts
4th Apr 20187:00 amRNSResults for the year ended 31 December 2017
3rd Apr 20189:01 amRNSProduct Announcement
28th Mar 20184:03 pmRNSNotice of Results
27th Mar 20182:14 pmRNSProduct Announcement
8th Mar 20187:00 amRNSSecond Interim Dividend
26th Feb 201810:17 amRNSCorrection - Product Announcement
26th Feb 20187:00 amRNSProduct Announcement
21st Feb 20187:00 amRNSProduct Announcement
23rd Jan 20187:00 amRNSProduct Announcement
21st Dec 20177:00 amRNSPre-Close Trading Update
30th Nov 20171:29 pmRNSProduct Announcement
18th Sep 20177:00 amRNSInterim Results for the six months ended 30 Jun 17
5th Sep 20177:00 amRNSNotice of Results
26th Jun 20177:00 amRNSProduct Announcement
25th May 20172:57 pmRNSResult of AGM
9th May 20177:00 amRNSNotice of AGM
12th Apr 20172:08 pmRNSDistribution of Annual Report and Accounts
30th Mar 201711:18 amRNSHolding(s) in Company
29th Mar 20174:33 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSFinal Results
22nd Mar 20177:00 amRNSNotice of Results
2nd Mar 201710:11 amRNSProduct Announcement
24th Feb 20177:00 amRNSSecond Interim Dividend
30th Jan 20179:23 amRNSProduct Announcement
13th Jan 20179:30 amRNSHolding(s) in Company
13th Jan 20179:30 amRNSHolding(s) in Company
20th Dec 20162:36 pmRNSPre-Close Trading Update
16th Dec 20163:13 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSProduct Launch
29th Sep 20167:00 amRNSProduct Launch
22nd Sep 20162:45 pmRNSTotal Voting Rights
9th Sep 201612:05 pmRNSDirector/PDMR Shareholding
30th Aug 20165:05 pmRNSHolding(s) in Company
30th Aug 201612:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSInterim Results
19th Aug 20162:21 pmRNSNotice of Interim Results
22nd Jul 20161:55 pmRNSHolding(s) in Company
1st Jul 20167:00 amRNSTrading Update
1st Jun 20162:43 pmRNSTotal Voting Rights
19th May 201612:56 pmRNSAGM Statement
12th May 20165:18 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSProduct Launch
19th Apr 20163:51 pmRNSDirector/PDMR Shareholding
19th Apr 201612:10 pmRNSDirector/PDMR Shareholding
18th Apr 20162:14 pmRNSDirector/PDMR Shareholding
18th Apr 201610:55 amRNSPosting of Annual Report & Accounts
29th Mar 20164:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.